Department of Pharmacy, Hua Mei Hospital, University of Chinese Academy of Sciences, Zhejiang, China.
Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangdong, China.
Front Endocrinol (Lausanne). 2022 May 16;13:880683. doi: 10.3389/fendo.2022.880683. eCollection 2022.
Non-alcoholic fatty liver disease (NAFLD) greatly affects cardiovascular disease, but evidence on the associations between NAFLD and markers of aortic calcification is limited. We aim to evaluate the association between NAFLD and aortic calcification in a cohort of Chinese adults using propensity score-matching (PSM) analysis.
This prospective cohort study involved adults who underwent health-screening examinations from 2009 to 2016. NAFLD was diagnosed by abdominal ultrasonography at baseline, and aortic calcification was identified using a VCT LightSpeed 64 scanner. Analyses included Cox proportional-hazards regression analysis and PSM with predefined covariates (age, gender, marital and smoking status, and use of lipid-lowering drugs) to achieve a 1:1 balanced cohort.
Of the 6,047 eligible participants, 2,729 (45.13%) were diagnosed with NAFLD at baseline, with a median age of 49.0 years [interquartile range, 44.0-55.0]. We selected 2,339 pairs of participants with and without NAFLD at baseline for the PSM subpopulation. Compared with those without NAFLD, patients with NAFLD were at a higher risk of developing aortic calcification during follow-up; significant results were observed before and after matching, with the full-adjusted hazard ratios and corresponding 95% confidence intervals being 1.19 (1.02-1.38) and 1.18 (1.01-1.38), respectively (both < 0.05). In subgroup analyses, no interaction was detected according to age, gender, smoking status, body mass index, total cholesterol, low-density lipoprotein cholesterol, use of lipid-lowering drugs, hypertension, or type 2 diabetes.
NAFLD may be independently associated with aortic calcification. Further studies are warranted to elucidate the possible underlying mechanisms.
非酒精性脂肪性肝病(NAFLD)对心血管疾病影响较大,但有关 NAFLD 与主动脉钙化标志物之间关联的证据有限。我们旨在通过倾向评分匹配(PSM)分析评估中国成年人队列中 NAFLD 与主动脉钙化之间的关系。
本前瞻性队列研究纳入了 2009 年至 2016 年期间接受健康筛查检查的成年人。NAFLD 于基线时通过腹部超声诊断,主动脉钙化则使用 VCT LightSpeed 64 扫描仪确定。分析包括 Cox 比例风险回归分析和 PSM 分析,PSM 分析采用了预先定义的协变量(年龄、性别、婚姻和吸烟状况以及降脂药物的使用)来实现 1:1 的均衡队列。
在 6047 名符合条件的参与者中,2729 名(45.13%)在基线时被诊断为 NAFLD,中位年龄为 49.0 岁[四分位距(IQR),44.0-55.0]。我们选择了 2339 对基线时患有和未患有 NAFLD 的参与者进行 PSM 亚组分析。与未患有 NAFLD 的患者相比,患有 NAFLD 的患者在随访期间发生主动脉钙化的风险更高;匹配前后均观察到显著结果,全调整风险比及其相应的 95%置信区间分别为 1.19(1.02-1.38)和 1.18(1.01-1.38)(均<0.05)。在亚组分析中,未根据年龄、性别、吸烟状况、体重指数、总胆固醇、低密度脂蛋白胆固醇、降脂药物的使用、高血压或 2 型糖尿病检测到交互作用。
NAFLD 可能与主动脉钙化独立相关。需要进一步的研究来阐明可能的潜在机制。